Mylan Rejects Teva’s $40 Billion Takeover Offer by MICHAEL J. de la MERCED

By MICHAEL J. de la MERCED

The move sets the stage for a fierce battle among three generic pharmaceutical giants.

Published: April 28, 2015 at 12:00AM

from NYT Business Day http://ift.tt/1GA9x8g

from WordPress http://ift.tt/1DD4E8w
via Hadi Aboukhater